Martin has worked extensively with the University sector, advising on technology transfer and commercialisation of innovative technologies. He is a member of the Bioengineering Advisory Board, Imperial College London and the Imperial Technology Experts Service. Martin was an Impact Assessor on the Clinical Medicine Panel for the UK Government Research Excellence Framework exercise during 2014.
Martin is also Programme Director of NIHR Invention for Innovation, a translational funding programme. i4i aims to support and advance the research and development of innovative healthcare technologies and their translation into the clinical environment for the benefit of patients. The programme has a current portfolio of c£170m invested in 200+ projects and has leveraged additional funding of over £94m. Martin is also a member of the NIHR Strategy Board, and is Chair or Board member of a number of NIHR initiatives.
Martin has raised over £50m public / private funding to support innovative technologies and is an active business angel.